NetworkNewsBreaks

WednesdayJan 11, 2017 3:33 pm

NetworkNewsBreaks – Guitammer (GTMM) Reports 475% Increase in FY2016 ButtKicker® Sales; Says 2017 Will Be Even Better

Reporting a triple-digit sales increase of its ButtKicker®-equipped cinema seats for full-year 2016, The Guitammer Company (OTCQB: GTMM) forecasts that its performance in 2017 will be even stronger. The Ohio-based company yesterday said it sold over 11,300 new ButtKicker®-equipped cinema seats for 57 new auditoriums in 2016, marking a 475% increase compared to 12 auditoriums and over 2,500 seats in 2015. There are now more than 20,000 ButtKicker-enabled seats in over 105 cinema auditoriums worldwide. The company also guided for continued growth this year, and said it expects to ship ButtKicker products for 1,000 seats in five new auditoriums by…

Continue Reading

WednesdayJan 11, 2017 3:26 pm

NetworkNewsBreaks – Petrogas (PTCO) Shares Climb on Acquisition of Fractional Interest in Texas

Shares of Petrogas Company (OTC: PTCO) are up 9% after the company said it has acquired a fractional interest in 11 oil and gas wells operated by Vanguard Operating (NASDAQ: VNR) in Cherokee County, Texas. Only some of the wells are currently producing hydrocarbons. "This is the type of acquisition we love to make as most of these wells had their production turned off in 2014 when oil prices began sliding. Now that prices are coming back to profitable levels, we expect that all offline wells could be brought back to production with minimal effort over the coming months," Petrogas…

Continue Reading

WednesdayJan 11, 2017 2:38 pm

NetworkNewsBreaks – Ironclad Performance Wear (ICPW) Strategizes to Buck Impact of Oil & Gas Uncertainties

Ironclad Performance Wear (OTCQB: ICPW) designs and manufactures work wear for various construction, do-it-yourself, industrial, sporting goods, and general services markets – a focus that generated third quarter 2016 sales of $6.45 million, up 19.1% year-over-year. The company specializes in task-specific gloves, such as the KONG® original, which was co-developed by the oil and gas industry safety committee for use in oil and gas drilling, extraction and refining, fracking, and many other construction-related fields. On the same note, Ironclad is hedging itself against struggles of the current oil and gas market, focusing on expansion in other key segments. To learn…

Continue Reading

WednesdayJan 11, 2017 2:30 pm

NetworkNewsBreaks – Sangamo Therapeutics, Inc. (NASDAQ: SGMO): FDA Grants Orphan Drug Designation for SB-318

Sangamo Therapeutics (NASDAQ: SGMO) is trading higher this morning on news the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. The FDA grants orphan drug designation to drugs and biologics intended to treat rare diseases, providing incentives to advance development of rare disease drugs as well as commercialization of drugs that progress to approval. Sangamo also noted its plans to “conduct the first ever in vivo genome editing clinical trials including Phase 1/2 studies…

Continue Reading

TuesdayJan 10, 2017 3:01 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 10, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DSGT 75.00% – News: Presenting product line at 2017 PGA Merchandise Show in Orlando XGTI 17.31% – News: Regains Nasdaq listing compliance CMXC 16.67% – News: Reports positive observational results of trial in Manila, Philippines KAYS 16.49% – News:  Receives full recreational marijuana retailer license from OLCC for South Salem Kaya Shack™; secures $2.1M funding commitment HPCQ 15.00% – News: Enters exclusive distributor agreement for Guatemala with Fertica Group TENG 14.75%– News: Advisement from…

Continue Reading

TuesdayJan 10, 2017 3:01 pm

NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Shares Surge on Coverage Agreement with Blue Cross Blue Shield of Texas

Shares of Biocept (NASDAQ: BIOC) are up 15% on word the molecular diagnostics company has obtained an in-network provider agreement with Blue Cross Blue Shield of Texas (BCBSTX). The company views the achievement as a milestone in expanding coverage for its Target Selector™ platform, as BCBSTX is the largest provider of health benefits in Texas. "Partnering with health insurers is a major focus of our business strategy, as it may increase physician access to this non-invasive technology for their patients and provide timely adjudication of claims for patients. Securing this in-network agreement is an important milestone for Biocept, as Texas…

Continue Reading

TuesdayJan 10, 2017 2:36 pm

NetworkNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) Receives U.S. FDA GRAS Status for SONOVA® GLA Safflower Oil, Expands Application Options

Arcadia Biosciences (NASDAQ: RKDA) this morning announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s conclusion that its SONOVA® GLA safflower oil is “generally recognized as safe” (GRAS) for use in nutritional beverages and medical foods. The company followed FDA-proposed procedures to establish its SONOVA® GLA (gamma-linolenic acid) safflower oil as GRAS under the intended conditions of use as a nutritional supplement product. “This FDA GRAS notification expands the application options for Arcadia’s SONOVA® GLA safflower oil, opening adjacent markets for our customers in nutritional beverages and medical foods,” president and CEO Raj Ketkar stated in…

Continue Reading

TuesdayJan 10, 2017 1:25 pm

NetworkNewsBreaks – Pluristem (NASDAQ: PSTI) Receives FDA Clearance for Phase 3 PLX-PAD Cells Study; Shares Higher

Shares of Pluristem Therapeutics (NASDAQ: PSTI) are up 7% mid-morning following news that the FDA has cleared the company’s phase 3 study of its PLX-PAD cells in the treatment of critical limb ischemia (CLI). Patients with CLI are at an immediate risk for limb amputation and death, and with meager treatment options, have a severe unmet medical need. The company said it intends to use the results of its study to submit a biologics license application to the FDA for marketing approval. The study is expected to begin patient enrollment in both the U.S. and Europe by June 2017.  “We…

Continue Reading

MondayJan 09, 2017 1:00 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 9, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: VPRB 12.50% – News: Names new COO VBIO 12.31% – News: Presenting at Biotech Showcase on January 11 in San Francisco CMXC 12.00% – News: Received the first eBalance Pro wellness devices SINO 10.16% – News: Enters joint venture agreement with Jetta Global Logistics RAVE 10.01% – News: Names new CEO APOP 7.69%– News: Major shareholder increases holdings CRNT 6.87% – News: Posts Q4 2016 financial results IMII 6.59% – News: Releases additional data…

Continue Reading

MondayJan 09, 2017 12:58 pm

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). The single dose study conducted to determine the concentration of CBD in the blood after chewing one CanChew Plus® Gum for 30 minutes showed positive results for the 30 mg dosage. This data will be used to determine the optimal concentration in the IBS patient trial. AXIM aims to provide a pharmaceutical…

Continue Reading